Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127057201 | 12705720 | 1 | I | 201510 | 20160829 | 20160901 | 20160901 | EXP | VN-ROCHE-1823656 | ROCHE | 56.00 | YR | M | Y | 0.00000 | 20160901 | MD | VN | VN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127057201 | 12705720 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Unknown | IN R-CHOP REGIMEN, 5 CYCLES | Y | 103705 | |||||||||
| 127057201 | 12705720 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Unknown | IN R-CVP REGIMEN | Y | 103705 | |||||||||
| 127057201 | 12705720 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | IN R-CHOP REGIMEN, 5 CYCLES | Y | 0 | |||||||||
| 127057201 | 12705720 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | IN R-CVP REGIMEN | Y | 0 | |||||||||
| 127057201 | 12705720 | 5 | SS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | IN R-CHOP REGIMEN, 5 CYCLES | Y | 0 | |||||||||
| 127057201 | 12705720 | 6 | SS | Vincristine | VINCRISTINE | 1 | Unknown | IN R-CHOP REGIMEN, 5 CYCLES | Y | 0 | |||||||||
| 127057201 | 12705720 | 7 | SS | Vincristine | VINCRISTINE | 1 | Unknown | IN R-CVP REGIMEN | Y | 0 | |||||||||
| 127057201 | 12705720 | 8 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | IN R-CHOP REGIMEN, 5 CYCLES | Y | 0 | |||||||||
| 127057201 | 12705720 | 9 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | IN R-CVP REGIMEN | Y | 0 | |||||||||
| 127057201 | 12705720 | 10 | C | ENTECAVIR. | ENTECAVIR | 1 | Oral | 1 TAB DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127057201 | 12705720 | 1 | Diffuse large B-cell lymphoma |
| 127057201 | 12705720 | 3 | Diffuse large B-cell lymphoma |
| 127057201 | 12705720 | 5 | Diffuse large B-cell lymphoma |
| 127057201 | 12705720 | 6 | Diffuse large B-cell lymphoma |
| 127057201 | 12705720 | 8 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127057201 | 12705720 | OT |
| 127057201 | 12705720 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127057201 | 12705720 | Cerebrovascular accident | |
| 127057201 | 12705720 | Disease progression | |
| 127057201 | 12705720 | Off label use | |
| 127057201 | 12705720 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127057201 | 12705720 | 1 | 201506 | 201510 | 0 | |
| 127057201 | 12705720 | 2 | 201602 | 0 | ||
| 127057201 | 12705720 | 3 | 201506 | 201510 | 0 | |
| 127057201 | 12705720 | 4 | 201602 | 0 | ||
| 127057201 | 12705720 | 5 | 201506 | 201510 | 0 | |
| 127057201 | 12705720 | 6 | 201506 | 201510 | 0 | |
| 127057201 | 12705720 | 7 | 201602 | 0 | ||
| 127057201 | 12705720 | 8 | 201506 | 201510 | 0 | |
| 127057201 | 12705720 | 9 | 201602 | 0 | ||
| 127057201 | 12705720 | 10 | 201506 | 0 |